[go: up one dir, main page]

DE69722610D1 - Neue Inhalationspräparate enthaltend CR 2039 (Andolast) - Google Patents

Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Info

Publication number
DE69722610D1
DE69722610D1 DE69722610T DE69722610T DE69722610D1 DE 69722610 D1 DE69722610 D1 DE 69722610D1 DE 69722610 T DE69722610 T DE 69722610T DE 69722610 T DE69722610 T DE 69722610T DE 69722610 D1 DE69722610 D1 DE 69722610D1
Authority
DE
Germany
Prior art keywords
andolast
preparations containing
pharmaceutically
inhalation preparations
new inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69722610T
Other languages
English (en)
Other versions
DE69722610T2 (de
Inventor
Francesco Makovec
Paolo Senin
Lucio Claudio Rovati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rottapharm SpA
Original Assignee
Rotta Research Laboratorium SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotta Research Laboratorium SpA filed Critical Rotta Research Laboratorium SpA
Application granted granted Critical
Publication of DE69722610D1 publication Critical patent/DE69722610D1/de
Publication of DE69722610T2 publication Critical patent/DE69722610T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE69722610T 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast) Expired - Lifetime DE69722610T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97830417A EP0896821B1 (de) 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Publications (2)

Publication Number Publication Date
DE69722610D1 true DE69722610D1 (de) 2003-07-10
DE69722610T2 DE69722610T2 (de) 2004-04-29

Family

ID=8230753

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69722610T Expired - Lifetime DE69722610T2 (de) 1997-08-08 1997-08-08 Neue Inhalationspräparate enthaltend CR 2039 (Andolast)

Country Status (9)

Country Link
US (1) US5976576A (de)
EP (1) EP0896821B1 (de)
JP (1) JP4301598B2 (de)
AT (1) ATE241980T1 (de)
AU (1) AU735204B2 (de)
CA (1) CA2244357C (de)
DE (1) DE69722610T2 (de)
ES (1) ES2199336T3 (de)
PT (1) PT896821E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0010709D0 (en) * 2000-05-03 2000-06-28 Vectura Ltd Powders for use a in dry powder inhaler
US7078423B2 (en) * 2002-07-18 2006-07-18 Inotek Pharmaceuticals Corporation 5-Aryltetrazole compounds, compositions thereof, and uses therefor
US7087631B2 (en) * 2002-07-18 2006-08-08 Inotek Pharmaceuticals Corporation Aryltetrazole compounds, and compositions thereof
US7037927B2 (en) * 2003-10-16 2006-05-02 Abbott Laboratories Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
JP2008502699A (ja) * 2004-06-14 2008-01-31 セプラコール・インコーポレイテッド 肺疾患治療方法、及びそのための組成物
EP1773325A4 (de) * 2004-06-14 2007-11-07 Sepracor Inc Verfahren zur verwendung von albuterol und calcium aktivierte kaliumkanalöffner
ATE404195T1 (de) * 2004-08-19 2008-08-15 Rottapharm Spa Verwendung von phenylbenzamide-derivaten zur behandlung von chronisch-obstruktiver lungenerkrankung (copd)
EP1978955A1 (de) * 2006-01-06 2008-10-15 Boehringer Ingelheim International GmbH Neue pharmazeutische zusammensetzungen auf basis von anticholinergika und andolast
EP1845093B1 (de) * 2006-04-10 2009-06-10 Rottapharm S.p.A. Neue kristalline und stabile Form von Andolast
DE602006021638D1 (en) * 2006-07-31 2011-06-09 Rottapharm Spa Kombination aus andolast/glucocorticoiden

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192772A (en) * 1987-12-09 1993-03-09 Nippon Shinyaku Co. Ltd. Therapeutic agents
IT1232252B (it) * 1989-02-22 1992-01-28 Rotta Research Lab Derivati della n fenil benzamide ad attivita' antiulcera ed antiallerica e procedimento per la loro preparazione
US5780051A (en) * 1992-04-02 1998-07-14 Dynagen, Inc. Methods and articles of manufacture for nicotine cessation and monitoring nicotine use
DE59309257D1 (de) * 1992-10-26 1999-02-11 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung von mikrokapseln
US5453368A (en) * 1993-08-27 1995-09-26 Brown University Research Foundation Method of encapsulating biological substances in microspheres
US5855913A (en) * 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5741168A (en) * 1996-06-21 1998-04-21 Chen; Ming-Sheng Toy glider as folded and assembled from two-dimensional elements

Also Published As

Publication number Publication date
EP0896821A1 (de) 1999-02-17
EP0896821B1 (de) 2003-06-04
DE69722610T2 (de) 2004-04-29
JP4301598B2 (ja) 2009-07-22
JPH11106339A (ja) 1999-04-20
AU7732798A (en) 1999-02-18
ATE241980T1 (de) 2003-06-15
PT896821E (pt) 2003-08-29
AU735204B2 (en) 2001-07-05
US5976576A (en) 1999-11-02
CA2244357A1 (en) 1999-02-08
ES2199336T3 (es) 2004-02-16
CA2244357C (en) 2007-05-01

Similar Documents

Publication Publication Date Title
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
CA2171275A1 (en) Stilbene derivatives and pharmaceutical compositions containing them
NO308848B1 (no) Kromanforbindelse og farmasøytisk preparat som inneholder den
CA2335065A1 (en) Pharmaceutical formulations for aerosols with two or more active substances
ITRM910696A1 (it) Composizioni farmaceutiche per l'applicazione per via nasale.
DE69523438D1 (de) Orale metoprolol-dosisform des typs "einmal täglich"
CY1107966T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν μετφορμινη και γλιβενκλαμιδη για τη θεραπεια του σακχαρωδους διαβητη τυπου ii
IT1241996B (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ATE218345T1 (de) Arzneimittel gegen spinocerebellare degeneration
BR9500758A (pt) Formulaçoes farmacêuticas para administraçao oral
CA2377174A1 (en) Oral administration forms for administering a fixed tramadol and diclofenac combination
DK581889A (da) Antiatherosclerotiske diarylforbindelser
DE69722610D1 (de) Neue Inhalationspräparate enthaltend CR 2039 (Andolast)
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
DK0521393T3 (da) Dichlofenac-cholinsalt, fremgangsmåde til fremstilling deraf og farmaceutiske præparater der indeholder det
TR200001121T2 (tr) Antiromatizmal madde.
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
EP0816366A4 (de) Imidazothiazolverbindungen
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
SE9101687D0 (sv) Dikloranilinfoerening
CA2154485A1 (en) Pharmaceutical composition containing 5-morpholinomethyl-3-(4-chlorobenzylideneamine)-2-oxazolidinone and its use for the treatment of cns disorders
ZA968315B (en) Administration by inhalation of 2-amino-6n-propyl-amino-4,5,,7-tetrahydrobenzothiazole particularly the (-)-enan-tiomer thereof and the pharmacologically acceptable acid addition salts thereof
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ROTTAPHARM S.P.A., MILANO, IT